T J Palker

6.7k total citations · 2 hit papers
53 papers, 5.4k citations indexed

About

T J Palker is a scholar working on Immunology, Agronomy and Crop Science and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, T J Palker has authored 53 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 23 papers in Agronomy and Crop Science and 18 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in T J Palker's work include T-cell and Retrovirus Studies (26 papers), Animal Disease Management and Epidemiology (23 papers) and Vector-Borne Animal Diseases (18 papers). T J Palker is often cited by papers focused on T-cell and Retrovirus Studies (26 papers), Animal Disease Management and Epidemiology (23 papers) and Vector-Borne Animal Diseases (18 papers). T J Palker collaborates with scholars based in United States, Canada and Japan. T J Palker's co-authors include Barton F. Haynes, Robert C. Gallo, Bijan Safai, Mikuláš Popovič, Syed Zaki Salahuddin, James M. Oleske, Paul S. Foster, Phillip D. Markham, Mark H. Kaplan and Gene M. Shearer and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

T J Palker

53 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1984 2.8k citations Robert C. Gallo, Mikuláš Popovič et al. profile →
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

1988 484 citations T J Palker, Michael E. Clark et al. profile →

Peers

Countries citing papers authored by T J Palker

Since Specialization

Citations

This map shows the geographic impact of T J Palker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T J Palker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T J Palker more than expected).

Fields of papers citing papers by T J Palker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T J Palker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T J Palker. The network helps show where T J Palker may publish in the future.

Co-authorship network of co-authors of T J Palker

This figure shows the co-authorship network connecting the top 25 collaborators of T J Palker. A scholar is included among the top collaborators of T J Palker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T J Palker. T J Palker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes 2005 ·Virology ·(unknown), (unknown), Loren D. Schultz, Ling Chen, Fubao Wang, (unknown), (unknown), Elmer Santos, Richard A. Moore, T J Palker, Margaret Stanley, Kathrin U. Jansen	27
2	Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants 2004 ·Virus Research ·T J Palker, Irina Kiseleva, (unknown), Qin Su, Timothy J. Toner, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Daniel J. DiStefano, Larisa Rudenko, Alan Shaw, Rima Youil	12
3	Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen 1998 ·AIDS ·John Bartlett, Steven S. Wasserman, Charles B. Hicks, (unknown), Kent J. Weinhold, Carol O. Tacket, Nzeera Ketter, Alec E. Wittek, T J Palker, Barton F. Haynes	35
4	Intranasal Immunization Is Superior to Vaginal, Gastric, or Rectal Immunization for the Induction of Systemic and Mucosal Anti-HIV Antibody Responses 1997 ·AIDS Research and Human Retroviruses ·Herman F. Staats, Sean P. Montgomery, T J Palker	85
5	Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo 1997 ·The Journal of Immunology ·Angel Porgador, Herman F. Staats, Brenda Faiola, Eli Gilboa, T J Palker	90
6	Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A) 1996 ·The Journal of Immunology ·Herman F. Staats, W. Garrett Nichols, T J Palker	126
7	Effect of bismuth salts on systemic and mucosal immune responses to orally administered cholera toxin 1995 ·Immunopharmacology ·Neil S. Horowitz, Herman F. Staats, T J Palker	1
8	Comparative Analysis of the Antibody Response to the HTLV‐I gag and env Proteins in HTLV‐I Asymptomatic Carriers and HAM/TSP Patients: an Isotype and Subclass Analysis 1994 ·Scandinavian Journal of Immunology ·Gregory A. Dekaban, Ewa King, J. Arp, T J Palker, George P. Rice	8
9	Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein. 1993 ·The Journal of Experimental Medicine ·Barton F. Haynes, L O Arthur, (unknown), Thomas J. Matthews, A J Langlois, T J Palker, Mary Kate Hart, Richard M. Scearce, Dawn Jones, Charlene McDanal	15
10	Antibody responses to the env epitopes of human T-lymphotropic virus type I in rhesus macaques naturally infected with simian T-lymphotropic virus type I 1993 ·Research in Virology ·Donna L. Rudolph, JoAnn L. Yee, T J Palker, J E Coligan, R. B. Lal	2
11	Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys. 1993 ·The Journal of Immunology ·Yasuhiro Yasutomi, T J Palker, (unknown), B F Haynes, N L Letvin	50
12	Expression and immunogenicity of the entire human T cell leukaemia virus type I envelope protein produced in a baculovirus system 1993 ·Journal of General Virology ·J. Arp, Christopher M. Ford, T J Palker, Ewa King, Gregory A. Dekaban	15
13	Characterization of the antibody response to three different versions of the HTLV-I envelope protein expressed by recombinant vaccinia viruses: Induction of neutralizing antibody 1992 ·Virology ·Christopher M. Ford, J. Arp, T J Palker, Ewa King, Gregory A. Dekaban	14
14	A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I 1991 ·Journal of General Virology ·Renu B. Lal, Donna L. Rudolph, T J Palker, J E Coligan, T M Folks	13
15	Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys. 1990 ·The Journal of Immunology ·Mary Kate Hart, T J Palker, Thomas J. Matthews, A J Langlois, Nicholas W. Lerche, (unknown), Richard M. Scearce, Charlene McDanal, D P Bolognesi, Barton F. Haynes	73
16	Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies. 1990 ·The Journal of Immunology ·Douglas S. Tyler, Sydney Stanley, Susan Zolla‐Pazner, Miroslaw K. Górny, Phillip P. Shadduck, A J Langlois, Thomas J. Matthews, Dani P. Bolognesi, T J Palker, Kent J. Weinhold	86
17	Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. 1989 ·The Journal of Immunology ·T J Palker, Thomas J. Matthews, A J Langlois, (unknown), (unknown), Richard M. Scearce, (unknown), Jay A. Berzofsky, D P Bolognesi, Barton F. Haynes	109
18	Human T-cell lymphotropic virus I and adult T-cell leukemia: Report of a cluster in North Carolina 1988 ·The American Journal of Medicine ·Jason B. Weinberg, Richard A. Spiegel, (unknown), Robert S. Janssen, Jonathan E. Kaplan, Marjorie Robert-Guroff, Mikuláš Popovič, Thomas J. Matthews, Barton F. Haynes, T J Palker	12
19	Purification of envelope glycoproteins of human T cell lymphotropic virus type I (HTLV-I) by affinity chromatography 1987 ·Journal of Virological Methods ·T J Palker, Michael E. Clark, M. G. Sarngadharan, Thomas J. Matthews	7
20	Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny. 1983 ·The Journal of Experimental Medicine ·Barton F. Haynes, Marjorie Robert-Guroff, Richard S. Metzgar, Genoveffa Franchini, V. S. Kalyanaraman, T J Palker, Robert C. Gallo	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact